7,543
Views
78
CrossRef citations to date
0
Altmetric
Original

Drugs and fracture repair

Pages 741-748 | Received 30 Sep 2005, Accepted 11 Nov 2005, Published online: 08 Jul 2009

  • Alkan A, Erdem E, Gunhan O, Karasu C. Histomorphometric evaluation of the effect of doxycycline on the healing of bone defects in experimental diabetes mellitus: a pilot study . J Oral Maxillofac Surg 2002; 60(8)898–904
  • Andreassen T T, Oxlund H. Local anabolic effects of growth hormone on intact bone and healing fractures in rats . Calcif Tissue Int 2003; 73(3)258–64
  • Andreassen T T, Ejersted C, Oxlund H. Intermittent parathyroid hormone (1–34) treatment increases callus formation and mechanical strength of healing rat fractures . J Bone Miner Res 1999; 14(6)960–8
  • Andreassen T T, Fledelius C, Ejersted C, Oxlund H. Increases in callus formation and mechanical strength of healing fractures in old rats treated with parathyroid hormone . Acta Orthop Scand 2001; 72(3)304–7
  • Arikawa T, Omura K, Morita I. Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells . J Cell Physiol 2004; 200(3)400–6
  • Aspenberg P. Avoid cox inhibitors after skeletal surgery . Acta Orthop Scand 2002; 73(5)489–90
  • Aspenberg P, Lohmander L S, Thorngren K G. Failure of bone induction by bone matrix in adult monkeys . J Bone Joint Surg (Br) 1988; 70(4)625–7
  • Aspenberg P, Basic N, Tagil M, Vukicevic S. Reduced expression of BMP-3 due to mechanical loading: a link between mechanical stimuli and tissue differentiation . Acta Orthop Scand 2000; 71(6)558–62
  • Bostrom M P, Aspenberg P, Jeppsson C, Salvati E A. Enhancement of bone formation in the setting of repeated tissue deformation . Clin Orthop 1998, 350 221–8
  • Chen W J, Jingushi S, Aoyama I, Anzai J, Hirata G, Tamura M, Iwamoto Y. Effects of FGF-2 on metaphyseal fracture repair in rabbit tibiae . J Bone Miner Metab 2004; 22(4)303–9
  • Einhorn T A. Do inhibitors of cyclooxygenase-2 impair bone healing . J Bone Miner Res 2002; 17(6)977–8
  • Fransen M, Neal B. Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty . Cochrane Database Syst Rev 2004; 3, CD001160
  • Friedlaender G E, Perry C R, Cole J D, Cook S D, Cierny G, Muschler G F, Zych G A, Calhoun J H, LaForte A J, Yin S. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg (Am) 2001, Suppl 1, 83-A (Pt 2) S151–8
  • Geesink R G, Hoefnagels N H, Bulstra S K. Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect . J Bone Joint Surg (Br) 1999; 81(4)710–8
  • Gerstenfeld L C, Thiede M, Seibert K, Mielke C, Phippard D, Svagr B, Cullinane D, Einhorn T A. Differential inhibition of fracture healing by non-selective and cyclooxy-genase-2 selective non-steroidal anti-inflammatory drugs . J Orthop Res 2003; 21(4)670–5
  • Giannoudis P V, MacDonald D A, Matthews S J, Smith R M, Furlong A J, De Boer P. Nonunion of the femoral diaphysis. The influence of reaming and non-steroidal anti-inflammatory drugs . J Bone Joint Surg (Br) 2000; 82(5)655–8
  • Govender S, Csimma C, Genant H K, Valentin-Opran A, Amit Y, Arbel R, Aro H, Atar D, Bishay M, Borner M G, Chiron P, Choong P, Cinats J, Courtenay B, Feibel R, Geulette B, Gravel C, Haas N, Raschke M, Hammacher E, van der Velde D, Hardy P, Holt M, Josten C, Ketterl R L, Lindeque B, Lob G, Mathevon H, McCoy G, Marsh D, Miller R, Munting E, Oevre S, Nordsletten L, Patel A, Pohl A, Rennie W, Reynders P, Rommens P M, Rondia J, Rossouw W C, Daneel P J, Ruff S, Ruter A, Santavirta S, Schildhauer T A, Gekle C, Schnettler R, Segal D, Seiler H, Snowdowne R B, Stapert J, Taglang G, Verdonk R, Vogels L, Weckbach A, Wentzensen A, Wisniewski T. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients . J Bone Joint Surg (Am) 2002; 84(12)2123–34
  • Halpin R A, Geer L A, Zhang K E, Marks T M, Dean D C, Jones A N, Melillo D, Doss G, Vyas K P. The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs . Drug Metab Dispos 2000; 28(10)1244–54
  • Huddleston P M, Steckelberg J M, Hanssen A D, Rouse M S, Bolander M E, Patel R. Ciprofloxacin inhibition of experimental fracture healing . J Bone Joint Surg (Am) 2000; 82(2)161–73
  • Jeppsson C, Aspenberg P. BMP-2 can inhibit bone healing. Bone-chamber study in rabbits . Acta Orthop Scand 1996; 67(6)589–92
  • Jeppsson C, Bostrom M, Aspenberg P. Intraosseous BMP implants in rabbits Inhibitory effect on bone formation . Acta Orthop Scand 1999; 70(1)77–83
  • Jeppsson C, Astrand J, Tagil M, Aspenberg P. A combination of bisphosphonate and BMP additives in impacted bone allografts . Acta Orthop Scand 2003; 74(4)483–9
  • Johnsson R, Stromqvist B, Aspenberg P. Randomized radiostereometric study comparing osteogenic protein-1 (BMP-7) and autograft bone in human noninstrumented posterolateral lumbar fusion: 2002 Volvo Award in clinical studies . Spine 2002; 27(23)2654–61
  • Kakiuchi M, Hosoya T, Takaoka K, Amitani K, Ono K. Human bone matrix gelatin as a clinical alloimplant. A retrospective review of 160 cases . Int Orthop 1985; 9(3)181–8
  • Kaneko H, Arakawa T, Mano H, Kaneda T, Ogasawara A, Nakagawa M, Toyama Y, Yabe Y, Kumegawa M, Hakeda Y. Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts . Bone 2000; 27(4)479–86
  • Kawaguchi H, Kurokawa T, Hanada K, Hiyama Y, Tamura M, Ogata E, Matsumoto T. Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats . Endocrinology 1994; 135(2)774–81
  • Kock H J, Werther S, Uhlenkott H, Taeger G. Influence of unfractionated and low-molecular-weight heparin on bone healing: an animal model . Unfallchirurg 2002; 105(9)791–6
  • Kristiansen T K, Ryaby J P, McCabe J, Frey J J, Roe L R. Accelerated healing of distal radial fractures with the use of specific, low-intensity ultrasound. A multicenter, prospective, randomized, double-blind, placebo-controlled study . J Bone Joint Surg (Am) 1997; 79(7)961–73
  • Lamparter S, Slight S H, Weber K T. Doxycycline and tissue repair in rats . J Lab Clin Med 2002; 139(5)295–302
  • Laursen M, Hoy K, Hansen E S, Gelineck J, Christensen F B, Bunger C E. Recombinant bone morphogenetic protein-7 as an intracorporal bone growth stimulator in unstable thoracolumbar burst fractures in humans: preliminary results . Eur Spine J 1999; 8(6)485–90
  • Levander G. A study on bone regeneration . Surg Gynecol Obstetrics 1938; 67(6)705–14
  • Lindsay R, Nieves J, Formica C, Henneman E, Woelfert L, Shen V, Dempster D, Cosman F. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis . Lancet 1997; 350(9077)550–5
  • Minkowitz B, Boskey A L, Lane J M, Pearlman H S, Vigorita V J. Effects of propranolol on bone metabolism in the rat . J Orthop Res 1991; 9(6)869–75
  • Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, Boyce B, Zhao M, Gutierrez G. Stimulation of bone formation in vitro and in rodents by statins . Science 1999; 286(5446)1946–9
  • Neal B C, Rodgers A, Clark T, Gray H, Reid I R, Dunn L, MacMahon S W. A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery . Acta Orthop Scand 2000; 71(2)122–8
  • Neer R M, Arnaud C D, Zanchetta J R, Prince R, Gaich G A, Reginster J Y, Hodsman A B, Eriksen E F, Ish-Shalom S, Genant H K, Wang O, Mitlak B H. Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis . N Engl J Med 2001; 344(19)1434–41
  • Norfleet A M, Bergmann J S, Carney D H. Thrombin peptide, TP508, stimulates angiogenic responses in animal models of dermal wound healing, in chick chorioallantoic membranes, and in cultured human aortic and microvascular endothelial cells . Gen Pharmacol 2000; 35(5)249–54
  • O'Connor J P, Simon A M. Sustained inhibition of cox-2 decreases fracture healing success. . J Bone Miner Res (Suppl 2) 2003; 18: 338
  • Paralkar V M, Grasser W A, Mansolf A L, Baumann A P, Owen T A, Smock S L, Martinovic S, Borovecki F, Vukicevic S, Ke H Z, Thompson D D. Regulation of BMP-7 expression by retinoic acid and prostaglandin E(2) . J Cell Physiol 2002; 190(2)207–17
  • Paralkar V M, Borovecki F, Ke H Z, Cameron K O, Lefker B, Grasser W A, Owen T A, Li M, DaSilva-Jardine P, Zhou M, Dunn R L, Dumont F, Korsmeyer R, Krasney P, Brown T A, Plowchalk D, Vukicevic S, Thompson D D. An EP2 receptor-selective prostaglandin E2 agonist induces bone healing . Proc Natl Acad Sci U S A 2003; 100(11)6736–40
  • Paulson S K, Zhang J Y, Breau A P, Hribar J D, Liu N W, Jessen S M, Lawal Y M, Cogburn J N, Gresk C J, Markos C S, Maziasz T J, Schoenhard G L, Burton E G. Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats . Drug Metab Dispos 2000; 28(5)514–21
  • Perry A C, Prpa B, Rouse M S, Piper K E, Hanssen A D, Steckelberg J M, Patel R. Levofloxacin and trovafloxacin inhibition of experimental fracture-healing . Clin Orthop 2003, 414: 95–100
  • Persson P-E, Nilsson O S, Berggren A-M. Long-time outcome of total hip arthroplasty. Effects of non-steroidal anti-inflammatory drugs . Acta Orthop 2005; 76: 735–40
  • Raschke M, Kolbeck S, Bail H, Schmidmaier G, Flyvbjerg A, Lindner T, Dahne M, Roenne I A, Haas N. Homologous growth hormone accelerates healing of segmental bone defects . Bone 2001; 29(4)368–73
  • Schlienger R G, Kraenzlin M E, Jick S S, Meier C R. Use of beta-blockers and risk of fractures . Jama 2004; 292(11)1326–32
  • Schmidmaier G, Wildemann B, Ostapowicz D, Kandziora F, Stange R, Haas N P, Raschke M. Long-term effects of local growth factor (IGF-I and TGF-beta 1) treatment on fracture healing. A safety study for using growth factors . J Orthop Res 2004; 22(3)514–9
  • Seebach C, Skripitz R, Andreassen T T, Aspenberg P. Intermittent parathyroid hormone (1–34) enhances mechanical strength and density of new bone after distraction osteogenesis in rats . J Orthop Res 2004; 22(3)472–8
  • Selye H. On the stimulation of new bone formation with parathyroid extract and irradiatedErgosterol . Endocrinology 1932; 16: 547–58
  • Sheller M R, Crowther R S, Kinney J H, Yang J, Di Jorio S, Breunig T, Carney D H, Ryaby J T. Repair of rabbit segmental defects with the thrombin peptide, TP508 . J Orthop Res 2004; 22(5)1094–9
  • Simon A M, Manigrasso M B, O'Connor J P. Cyclo-oxy-genase 2 function is essential for bone fracture healing . J Bone Miner Res 2002; 17(6)963–76
  • Skoglund B, Forslund C, Aspenberg P. Simvastatin improves fracture healing in mice . J Bone Miner Res 2002; 17(11)2004–8
  • Skripitz R, Aspenberg P. Implant fixation enhanced by intermittent treatment with parathyroid hormone . J Bone Joint Surg (Br) 2001a; 83(3)437–40
  • Skripitz R, Aspenberg P. Parathyroid hormone (1–34) increases attachment of PMMA cement to bone . J Orthop Sci 2001b; 6(6)540–4
  • Skripitz R, Andreassen T T, Aspenberg P. Parathyroid hormone (1–34) increases the density of rat cancellous bone in a bone chamber. A dose-response study . J Bone Joint Surg (Br) 2000a; 82(1)138–41
  • Skripitz R, Andreassen T T, Aspenberg P. Strong effect of PTH (1–34) on regenerating bone: a time sequence study in rats . Acta Orthop Scand 2000b; 71(6)619–24
  • Stinchfield F E, Sankaran B, Samilson R. The effect of anti-coagulant therapy on bone repair . J Bone Joint Surg (Am) 1956; 38(2)270–82
  • Street J T, McGrath M, O'Regan K, Wakai A, McGuinness A, Redmond H P. Thromboprophylaxis using a low molecular weight heparin delays fracture repair . Clin Orthop 2000, 381: 278–89
  • Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker K L, Armstrong D, Ducy P, Karsenty G. Leptin regulates bone formation via the sympathetic nervous system . Cell 2002; 111(3)305–17
  • Tanaka M, Sakai A, Uchida S, Tanaka S, Nagashima M, Katayama T, Yamaguchi K, Nakamura T. Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats . Bone 2004; 34(6)940–8
  • Urist M. Bone: formation by autoinduction. . Science 1965; 150(698)893–9
  • Wahlstrom O. Stimulation of fracture healing with electromagnetic fields of extremely low frequency (EMF of ELF) . Clin Orthop 1984, 186: 293–301
  • Wang H, Li X, Tomin E, Doty S B, Lane J M, Carney D H, Ryaby J T. Thrombin peptide (TP508) promotes fracture repair by up-regulating inflammatory mediators, early growth factors, and increasing angiogenesis . J Orthop Res 2005; 23(3)671–9
  • Waters R V, Gamradt S C, Asnis P, Vickery B H, Avnur Z, Hill E, Bostrom M. Systemic corticosteroids inhibit bone healing in a rabbit ulnar osteotomy model . Acta Orthop Scand 2000; 71(3)316–21
  • Zhang X, Schwarz E M, Young D A, Puzas J E, Rosier R N, O'Keefe R J. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair . J Clin Invest 2002; 109(11)1405–15

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.